CD8A and neoplasm: These approaches have mostly targeted tumor-reactive CD8+ T cells, but in view of the important role (194–196) and efficacy of tumor-reactive CD4+ T cells (197–199) strategies to rapidly isolate that specific T cell fraction are needed.